SAN CARLOS, Calif., June 29, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc., (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Company has resumed cases in the CardiAMP Heart Failure Trial. The first patient procedure completed since elective procedures were paused due to […]
Coronary/Structural Heart
Neovasc Reducer™ and Tiara™ Featured at Leading Industry Virtual Conferences
VANCOUVER and MINNEAPOLIS, MN, June 29, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced that the Neovasc Reducer™ (“Reducer”) and Tiara™ (“Tiara”) program were recently featured at two industry conferences. The Tiara Mitral Valve Replacement program was featured at both the PCR e-Course […]
Mezzion Announces Submission of New Drug Application for its Orphan Drug Udenafil to Treat Patients who have undergone the Fontan Operation for Single Ventricle Heart Disease
Submitted for FDA Priority Review as a Rare Pediatric Disease Product Application SEOUL, South Korea, June 30, 2020 /PRNewswire/ — Mezzion Pharma Co. Ltd. (140410.KQ), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of udenafil to improve the physiology of patients 12 […]
Manipal Hospitals Performs Quadruple Valve Procedure for the First Time in Karnataka Amidst Pandemic
BANGALORE, June 30, 2020 /PRNewswire/ — Manipal Hospitals Bangalore performed quadruple valve procedure for the first time in Karnataka to give new lease of life to 38-year-old male patient. Dr. Devananda N S, HOD & Consultant – Cardiothoracic Vascular Surgery, Heart and Lung Transplant Surgery, Manipal Hospitals Old Airport Road, performed this […]
Interim Analysis of Recardio’s Phase II Clinical Trial to Be Presented at the 2020 Congress of the European Society of Cardiology
Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that the results of the interim analysis of Recardio’s Phase II clinical trial will be presented at the 2020 Congress of the European Society of Cardiology from August 29 through September 1. SAN FRANCISCO, June 29, 2020 /PRNewswire/ — Entitled […]
New Study Shows Datos Health’s Remote Care Platform Can Increase Patient Adherence to Cardiac Rehabilitation, and Result in Functional Improvement
First-of-its-Kind Clinical Study Indicates Significant Improvement in Exercise Capacity, Suggests Tele-Cardiac Rehab From Home is Viable Alternative to Center-Based Programs TEL AVIV, Israel, June 30, 2020 /PRNewswire/ — Datos Health, provider of hospital-grade automated remote care and telemedicine platforms, announced today the results of new research with Sheba Medical Center, showing that tele-cardiac rehabilitation […]
Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal – Circulation
WINNIPEG, MB, June 29, 2020 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, today announced that results from the investigator sponsored FABOLUS-FASTER Phase 4 clinical trial, using AGGRASTAT®, have been published in Circulation, a peer-reviewed journal of the American Heart Association. FABOLUS-FASTER studied different regimens of intravenous […]
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon
NYON, Switzerland, June 30, 2020 /PRNewswire/ — MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as in-stent restenosis. The approval applies to a broad […]
New Research Finds Abbott’s Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages
— Using optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI), physicians were able to select the right size stents and place them with greater precision — Imaging techniques such as OCT have been shown to improve outcomes during stenting procedures¹, but remain underutilized in global clinical settings due to lack […]
Neovasc Announces Positive Interim Results from REDUCER-I Study
VANCOUVER and MINNEAPOLIS, June 26, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced positive interim results of the REDUCER-I study during the PCR E-Course. Stefan Verheye, MD, PhD, ZNA Middelheim, Antwerp, Belgium presented the results of the trial during the Hotline and Innovation […]
Recent
Popular
- No commented posts yet